Increased risk of reflux esophagitis in non-obese individuals with nonalcoholic fatty liver disease: a cross-sectional study

References

• Broderick R, Fuchs KH, Breithaupt W, et al. Clinical presentation of gastroesophageal reflux disease: a prospective study on symptom diversity and modification of questionnaire application. Dig Dis. 2020;38(3):1–7. Epub 2019 Sep 12. PMID: 31514190. doi: 10.1159/000502796.
   PubMed Web of Science ®Google Scholar
• Boeckxstaens G, El-Serag HB, Smout AJ, et al. Symptomatic reflux disease: the present, the past and the future. Gut. 2014;63(7):1185–1193. Epub 2014 Mar 7. PMID: 24607936; PMCID: PMC4078752. doi: 10.1136/gutjnl-2013-306393.
   PubMed Web of Science ®Google Scholar
• Eusebi LH, Ratnakumaran R, Yuan Y, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018;67(3):430–440. Epub 2017 Feb 23. PMID: 28232473. doi: 10.1136/gutjnl-2016-313589.
   PubMed Web of Science ®Google Scholar
• Taraszewska A. Risk factors for gastroesophageal reflux disease symptoms related to lifestyle and diet. Rocz Panstw Zakl Hig. 2021;72(1):21–28. PMID: 33882662. doi: 10.32394/rpzh.2021.0145.
   PubMedGoogle Scholar
• Takahashi K, Seki Y, Kasama K, et al. Prevalence of reflux esophagitis in obese Japanese undergoing bariatric surgery. JGH Open. 2019;4(3):519–524. PMID: 32514464; PMCID: PMC7273729. doi: 10.1002/jgh3.12293.
   PubMed Web of Science ®Google Scholar
• Martín-Domínguez V, González-Casas R, Mendoza-Jiménez-Ridruejo J, et al. Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease. Rev Esp Enferm Dig. 2013;105(7):409–420. PMID: 24206551. doi: 10.4321/s1130-01082013000700006.
   PubMed Web of Science ®Google Scholar
• Li J, Zou B, Yeo YH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389–398. doi: 10.1016/S2468-1253(19)30039-1.Epub 2019 Mar 20. PMID: 30902670.
   PubMed Web of Science ®Google Scholar
• Ishido S, Tamaki N, Takahashi Y, et al. Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease. BMC Gastroenterol. 2023;23(1):211. PMID: 37330485; PMCID: PMC10276489. doi: 10.1186/s12876-023-02848-7.
   PubMed Web of Science ®Google Scholar
• Chen C, Zhu Z, Mao Y, et al. HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels. Biosci Rep. 2020;40(1):BSR20193996. PMID: 31940026; PMCID: PMC6997109. doi: 10.1042/BSR20193996.
   PubMedGoogle Scholar
• Mantovani A, Petracca G, Beatrice G, et al. Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies. Gut. 2022;71(4):778–788. Epub 2021 Mar 8. PMID: 33685968. doi: 10.1136/gutjnl-2021-324191.
   PubMed Web of Science ®Google Scholar
• Hung WC, Wu JS, Yang YC, et al. Nonalcoholic fatty liver disease vs. obesity on the risk of erosive oesophagitis. Eur J Clin Invest. 2014;44(12):1143–1149. Epub 2014 Nov 3. PMID: 25293867. doi: 10.1111/eci.12348.
   PubMed Web of Science ®Google Scholar
• Yang HJ, Chang Y, Park SK, et al. Nonalcoholic fatty liver disease is associated with increased risk of reflux esophagitis. Dig Dis Sci. 2017;62(12):3605–3613. Epub 2017 Oct 23. PMID: 29063416. doi: 10.1007/s10620-017-4805-6.
   PubMed Web of Science ®Google Scholar
• Min YW, Kim Y, Gwak GY, et al. Non-alcoholic fatty liver disease and the development of reflux esophagitis: a cohort study. J Gastroenterol Hepatol. 2018;33(5):1053–1058. Epub 2018 Feb 15. PMID: 29131401. doi: 10.1111/jgh.14042.
   PubMed Web of Science ®Google Scholar
• Bang KB, Shin JE, Shin HD, et al. Non-obese non- alcoholic fatty liver disease is associted with erosive esophagitis. Gastroenterology. 2018;154(6):S-241. doi: 10.1016/S0016-5085(18)31184-3.
   Web of Science ®Google Scholar
• Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45(2):172–180. PMID: 10403727; PMCID: PMC1727604. doi: 10.1136/gut.45.2.172.
   PubMed Web of Science ®Google Scholar
• Fan JG, Jia JD, Li YM, et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of hepatology 2010:18:163–166). J Dig Dis. 2011;12(1):38–44. doi: 10.1111/j.1751-2980.2010.00476.x.
   PubMed Web of Science ®Google Scholar
• Bao Y, Lu J, Wang C, et al. Optimal waist circumference cutoffs for abdominal obesity in chinese. Atherosclerosis. 2008;201(2):378–384. Epub 2008 Mar 18. PMID: 18417137. doi: 10.1016/j.atherosclerosis.2008.03.001.
   PubMed Web of Science ®Google Scholar
• Krigel A, Lebwohl B, Yadlapati R, et al. Association of patient gender and gastroenterologists’ diagnosis and management choices in gastroesophageal reflux disease. Dis Esophagus. 2021;34(9):doab019. PMID: 33870435. doi: 10.1093/dote/doab019.
   PubMed Web of Science ®Google Scholar
• Chung SJ, Kim D, Park MJ, et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut. 2008;57(10):1360–1365. Epub 2008 Apr 25. PMID: 18441006. doi: 10.1136/gut.2007.147090.
   PubMed Web of Science ®Google Scholar
• Chung TH, Lee J, Jeong ID, et al. Effect of weight changes on the development of erosive esophagitis. Korean J Fam Med. 2020;41(1):14–19. Epub 2020 Jan 9. PMID: 31914725; PMCID: PMC6987027. doi: 10.4082/kjfm.19.0003.
   PubMed Web of Science ®Google Scholar
• McColl KEL. What is causing the rising incidence of esophageal adenocarcinoma in the west and will it also happen in the east? J Gastroenterol. 2019; 54(8):669–673. Epub 2019 Jun 6. PMID: 31172291; PMCID: PMC6647360. doi: 10.1007/s00535-019-01593-7.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Furuta K, Adachi K, et al. Effects of anti-hypertensive drugs on esophageal body contraction. World J Gastroenterol. 2010;16(8):987–991. 8 PMID: 20180238; PMCID: PMC2828604. doi: 10.3748/wjg.v16.i8.987.
   PubMed Web of Science ®Google Scholar
• Hirata A, Kishida K, Nakatsuji H, et al. High prevalence of gastroesophageal reflux symptoms in type 2 diabetics with hypoadiponectinemia and metabolic syndrome. Nutr Metab. 2012;9(1):4 PMID: 22277344; PMCID: PMC3293023. doi: 10.1186/1743-7075-9-4.
   Google Scholar
• Toki Y, Yamauchi R, Kayashima E, et al. Predictive factors for future onset of reflux esophagitis: a longitudinal case-control study using health checkup records. J Neurogastroenterol Motil. 2022;28(1):86–94. PMID: 34980691; PMCID: PMC8748855. doi: 10.5056/jnm20237.
   PubMed Web of Science ®Google Scholar
• Cheng SM, Hung KL, Wang YJ, et al. Influence of gastric morphology on gastroesophageal reflux in adults: an observational study. Medicine . 2021;100(38):e27241.). PMID: 34559123; PMCID: PMC8462620. doi: 10.1097/MD.0000000000027241.
   PubMed Web of Science ®Google Scholar
• Hsieh YH, Wu MF, Yang PY, et al. What is the impact of metabolic syndrome and its components on reflux esophagitis? A cross-sectional study. BMC Gastroenterol. 2019;19(1):33. PMID: 30782138; PMCID: PMC6381695. doi: 10.1186/s12876-019-0950-z.
   PubMedGoogle Scholar
• Wijarnpreecha K, Panjawatanan P, Thongprayoon C, et al. Association between gastroesophageal reflux disease and nonalcoholic fatty liver disease: a meta-analysis. Saudi J Gastroenterol. 2017;23(6):311–317. PMID: 29205182; PMCID: PMC5738791. doi: 10.4103/sjg.SJG_161_17.
   PubMed Web of Science ®Google Scholar
• Choi JS, Kim HM, Yang YJ, et al. Fatty liver disease and the risk of erosive oesophagitis in the Korean population: a cross-sectional study. BMJ Open. 2019;9(1):e023585. PMID: 30705240; PMCID: PMC6359731. doi: 10.1136/bmjopen-2018-023585.
   PubMed Web of Science ®Google Scholar
• Rieder F, Biancani P, Harnett K, et al. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 2010;298(5):G571–81. Epub 2010 Mar 18. PMID: 20299604; PMCID: PMC286741 doi: 10.1152/ajpgi.00454.2009.
   PubMed Web of Science ®Google Scholar
• Han D, Zhang C. The oxidative damage and inflammation mechanisms in GERD-induced Barrett’s esophagus. Front Cell Dev Biol. 2022;10:885537. PMID: 35721515; PMCID: PMC9199966. doi: 10.3389/fcell.2022.885537.
   PubMed Web of Science ®Google Scholar
• Pardak P, Filip R, Woliński J, et al. Associations of obstructive sleep apnea, obestatin, leptin, and ghrelin with gastroesophageal reflux. J Clin Med. 2021;10(21):5195. PMID: 34768715; PMCID: PMC8584398. doi: 10.3390/jcm10215195.
   PubMed Web of Science ®Google Scholar